Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1014 Canaan
BioCentury & Getty Images

Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

Canaan plans to ramp up biopharma company formation out of its twelfth fund

Canaan Partners plans to ramp up biopharma company formation out of its twelfth fund.

By Virginia Li, Associate

Read the full 515 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE